Insight Molecular Diagnostics Shares Outstanding 2014-2025 | IMDX
Insight Molecular Diagnostics shares outstanding from 2014 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
| Insight Molecular Diagnostics Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024 | 13 |
| 2023 | 8 |
| 2022 | 6 |
| 2021 | 4 |
| 2020 | 3 |
| 2019 | 3 |
| 2018 | 2 |
| 2017 | 2 |
| 2016 | 1 |
| 2015 | 1 |
| 2014 | 1 |
| 2013 | 1 |
| Insight Molecular Diagnostics Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025-03-31 | 26 |
| 2024-12-31 | 13 |
| 2024-09-30 | 14 |
| 2024-06-30 | 13 |
| 2024-03-31 | 8 |
| 2023-12-31 | 8 |
| 2023-09-30 | 8 |
| 2023-06-30 | 8 |
| 2023-03-31 | 6 |
| 2022-12-31 | 6 |
| 2022-09-30 | 6 |
| 2022-06-30 | 6 |
| 2022-03-31 | 5 |
| 2021-12-31 | 4 |
| 2021-09-30 | 5 |
| 2021-06-30 | 4 |
| 2021-03-31 | 4 |
| 2020-12-31 | 3 |
| 2020-09-30 | 3 |
| 2020-06-30 | 3 |
| 2020-03-31 | 3 |
| 2019-12-31 | 3 |
| 2019-09-30 | 3 |
| 2019-06-30 | 3 |
| 2019-03-31 | 2 |
| 2018-12-31 | 2 |
| 2018-09-30 | 2 |
| 2018-06-30 | 2 |
| 2018-03-31 | 2 |
| 2017-12-31 | 2 |
| 2017-09-30 | 2 |
| 2017-06-30 | 1 |
| 2017-03-31 | 1 |
| 2016-12-31 | 1 |
| 2016-09-30 | 1 |
| 2016-06-30 | 1 |
| 2016-03-31 | 1 |
| 2015-12-31 | 1 |
| 2015-09-30 | 1 |
| 2015-06-30 | 1 |
| 2015-03-31 | 1 |
| 2014-12-31 | |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.087B | $0.002B |
| Insight Molecular Diagnostics Inc. is a pioneering diagnostics technology company. Insight Molecular Diagnostics Inc., formerly known as Oncocyte Corporation, is based in NASHVILLE, Tenn. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.182B | 58.76 |
| Doximity (DOCS) | United States | $11.140B | 51.57 |
| Hims & Hers Health (HIMS) | United States | $10.623B | 110.37 |
| Tempus AI (TEM) | United States | $10.245B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.558B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.855B | 60.24 |
| Hinge Health (HNGE) | United States | $3.480B | 0.00 |
| Privia Health (PRVA) | United States | $2.672B | 182.67 |
| Enovis (ENOV) | United States | $1.911B | 10.66 |
| Phreesia (PHR) | United States | $1.730B | 0.00 |
| 10x Genomics (TXG) | United States | $1.602B | 0.00 |
| Schrodinger (SDGR) | United States | $1.538B | 0.00 |
| Azenta (AZTA) | United States | $1.504B | 69.89 |
| Omnicell (OMCL) | United States | $1.396B | 24.63 |
| Evolent Health (EVH) | United States | $1.377B | 117.30 |
| Clover Health Investments (CLOV) | United States | $1.318B | 0.00 |
| Claritev (CTEV) | United States | $0.699B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.612B | 0.00 |
| Veradigm (MDRX) | United States | $0.525B | 0.00 |
| Standard BioTools (LAB) | United States | $0.520B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.485B | 0.00 |
| Talkspace (TALK) | United States | $0.440B | 131.50 |
| Outset Medical (OM) | United States | $0.365B | 0.00 |
| TruBridge (TBRG) | United States | $0.340B | 755.33 |
| Health Catalyst (HCAT) | United States | $0.283B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.262B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.203B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.168B | 0.00 |
| American Well (AMWL) | United States | $0.134B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.131B | 0.00 |
| Pulmonx (LUNG) | United States | $0.110B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.104B | 0.00 |
| CareCloud (CCLD) | United States | $0.104B | 3.95 |
| 111 (YI) | China | $0.063B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.049B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.048B | 0.00 |
| HeartBeam (BEAT) | United States | $0.044B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.040B | 0.00 |
| Zhongchao (ZCMD) | China | $0.030B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.015B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.010B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |